Celgene, 5.7% 15oct2040, USD (FIGI BBG001721H88, WKN A1A2E5)
国内債券, トレース適格, Senior Unsecured
国内債券, トレース適格, Senior Unsecured
|
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡